The Subcutaneous Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Subcutaneous Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Subcutaneous Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Subcutaneous Injection Equipment segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, and GSK, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Subcutaneous Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Subcutaneous Injection Equipment
- Subcutaneous Injection Drug
- Others
Market segment by Application, can be divided into
- Hospital
- Clinic
- Laboratory
- Others
Market segment by players, this report covers
- Becton Dickinson
- Daiichi Sankyo
- Sanofi
- Roche
- GSK
- Eli Lilly
- Asahi Kasei Pharma
- Takeda Pharmaceutical
- Antares Pharma, Inc.
- Eisai Co.,Ltd
- Chugai Pharmaceutical
- Endo International
- PenJet Corporation
- Aspen Medical Group
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Subcutaneous Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Subcutaneous Injection, with revenue, gross margin and global market share of Subcutaneous Injection from 2019 to 2022.
Chapter 3, the Subcutaneous Injection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Injection market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Subcutaneous Injection research findings and conclusion, appendix and data source.
Global Subcutaneous Injection Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Injection
1.2 Classification of Subcutaneous Injection by Type
1.2.1 Overview: Global Subcutaneous Injection Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Subcutaneous Injection Revenue Market Share by Type in 2021
1.2.3 Subcutaneous Injection Equipment
1.2.4 Subcutaneous Injection Drug
1.2.5 Others
1.3 Global Subcutaneous Injection Market by Application
1.3.1 Overview: Global Subcutaneous Injection Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Subcutaneous Injection Market Size & Forecast
1.5 Global Subcutaneous Injection Market Size and Forecast by Region
1.5.1 Global Subcutaneous Injection Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Subcutaneous Injection Market Size by Region, (2017-2022)
1.5.3 North America Subcutaneous Injection Market Size and Prospect (2017-2028)
1.5.4 Europe Subcutaneous Injection Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Subcutaneous Injection Market Size and Prospect (2017-2028)
1.5.6 South America Subcutaneous Injection Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Subcutaneous Injection Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Injection Market Drivers
1.6.2 Subcutaneous Injection Market Restraints
1.6.3 Subcutaneous Injection Trends Analysis
2 Company Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business
2.1.3 Becton Dickinson Subcutaneous Injection Product and Solutions
2.1.4 Becton Dickinson Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Becton Dickinson Recent Developments and Future Plans
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo Subcutaneous Injection Product and Solutions
2.2.4 Daiichi Sankyo Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Daiichi Sankyo Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Subcutaneous Injection Product and Solutions
2.3.4 Sanofi Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Subcutaneous Injection Product and Solutions
2.4.4 Roche Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK Subcutaneous Injection Product and Solutions
2.5.4 GSK Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GSK Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Subcutaneous Injection Product and Solutions
2.6.4 Eli Lilly Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Asahi Kasei Pharma
2.7.1 Asahi Kasei Pharma Details
2.7.2 Asahi Kasei Pharma Major Business
2.7.3 Asahi Kasei Pharma Subcutaneous Injection Product and Solutions
2.7.4 Asahi Kasei Pharma Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Asahi Kasei Pharma Recent Developments and Future Plans
2.8 Takeda Pharmaceutical
2.8.1 Takeda Pharmaceutical Details
2.8.2 Takeda Pharmaceutical Major Business
2.8.3 Takeda Pharmaceutical Subcutaneous Injection Product and Solutions
2.8.4 Takeda Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.9 Antares Pharma, Inc.
2.9.1 Antares Pharma, Inc. Details
2.9.2 Antares Pharma, Inc. Major Business
2.9.3 Antares Pharma, Inc. Subcutaneous Injection Product and Solutions
2.9.4 Antares Pharma, Inc. Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Antares Pharma, Inc. Recent Developments and Future Plans
2.10 Eisai Co.?Ltd
2.10.1 Eisai Co.?Ltd Details
2.10.2 Eisai Co.?Ltd Major Business
2.10.3 Eisai Co.?Ltd Subcutaneous Injection Product and Solutions
2.10.4 Eisai Co.?Ltd Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Eisai Co.?Ltd Recent Developments and Future Plans
2.11 Chugai Pharmaceutical
2.11.1 Chugai Pharmaceutical Details
2.11.2 Chugai Pharmaceutical Major Business
2.11.3 Chugai Pharmaceutical Subcutaneous Injection Product and Solutions
2.11.4 Chugai Pharmaceutical Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Chugai Pharmaceutical Recent Developments and Future Plans
2.12 Endo International
2.12.1 Endo International Details
2.12.2 Endo International Major Business
2.12.3 Endo International Subcutaneous Injection Product and Solutions
2.12.4 Endo International Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Endo International Recent Developments and Future Plans
2.13 PenJet Corporation
2.13.1 PenJet Corporation Details
2.13.2 PenJet Corporation Major Business
2.13.3 PenJet Corporation Subcutaneous Injection Product and Solutions
2.13.4 PenJet Corporation Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 PenJet Corporation Recent Developments and Future Plans
2.14 Aspen Medical Group
2.14.1 Aspen Medical Group Details
2.14.2 Aspen Medical Group Major Business
2.14.3 Aspen Medical Group Subcutaneous Injection Product and Solutions
2.14.4 Aspen Medical Group Subcutaneous Injection Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Aspen Medical Group Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Subcutaneous Injection Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Subcutaneous Injection Players Market Share in 2021
3.2.2 Top 10 Subcutaneous Injection Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Subcutaneous Injection Players Head Office, Products and Services Provided
3.4 Subcutaneous Injection Mergers & Acquisitions
3.5 Subcutaneous Injection New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Subcutaneous Injection Revenue and Market Share by Type (2017-2022)
4.2 Global Subcutaneous Injection Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Subcutaneous Injection Revenue Market Share by Application (2017-2022)
5.2 Global Subcutaneous Injection Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Subcutaneous Injection Revenue by Type (2017-2028)
6.2 North America Subcutaneous Injection Revenue by Application (2017-2028)
6.3 North America Subcutaneous Injection Market Size by Country
6.3.1 North America Subcutaneous Injection Revenue by Country (2017-2028)
6.3.2 United States Subcutaneous Injection Market Size and Forecast (2017-2028)
6.3.3 Canada Subcutaneous Injection Market Size and Forecast (2017-2028)
6.3.4 Mexico Subcutaneous Injection Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Subcutaneous Injection Revenue by Type (2017-2028)
7.2 Europe Subcutaneous Injection Revenue by Application (2017-2028)
7.3 Europe Subcutaneous Injection Market Size by Country
7.3.1 Europe Subcutaneous Injection Revenue by Country (2017-2028)
7.3.2 Germany Subcutaneous Injection Market Size and Forecast (2017-2028)
7.3.3 France Subcutaneous Injection Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Subcutaneous Injection Market Size and Forecast (2017-2028)
7.3.5 Russia Subcutaneous Injection Market Size and Forecast (2017-2028)
7.3.6 Italy Subcutaneous Injection Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Subcutaneous Injection Revenue by Type (2017-2028)
8.2 Asia-Pacific Subcutaneous Injection Revenue by Application (2017-2028)
8.3 Asia-Pacific Subcutaneous Injection Market Size by Region
8.3.1 Asia-Pacific Subcutaneous Injection Revenue by Region (2017-2028)
8.3.2 China Subcutaneous Injection Market Size and Forecast (2017-2028)
8.3.3 Japan Subcutaneous Injection Market Size and Forecast (2017-2028)
8.3.4 South Korea Subcutaneous Injection Market Size and Forecast (2017-2028)
8.3.5 India Subcutaneous Injection Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Subcutaneous Injection Market Size and Forecast (2017-2028)
8.3.7 Australia Subcutaneous Injection Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Subcutaneous Injection Revenue by Type (2017-2028)
9.2 South America Subcutaneous Injection Revenue by Application (2017-2028)
9.3 South America Subcutaneous Injection Market Size by Country
9.3.1 South America Subcutaneous Injection Revenue by Country (2017-2028)
9.3.2 Brazil Subcutaneous Injection Market Size and Forecast (2017-2028)
9.3.3 Argentina Subcutaneous Injection Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Subcutaneous Injection Revenue by Type (2017-2028)
10.2 Middle East & Africa Subcutaneous Injection Revenue by Application (2017-2028)
10.3 Middle East & Africa Subcutaneous Injection Market Size by Country
10.3.1 Middle East & Africa Subcutaneous Injection Revenue by Country (2017-2028)
10.3.2 Turkey Subcutaneous Injection Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Subcutaneous Injection Market Size and Forecast (2017-2028)
10.3.4 UAE Subcutaneous Injection Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Subcutaneous Injection Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Subcutaneous Injection Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Subcutaneous Injection Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Subcutaneous Injection Revenue (USD Million) by Region (2017-2022)
Table 5. Global Subcutaneous Injection Revenue Market Share by Region (2023-2028)
Table 6. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 7. Becton Dickinson Major Business
Table 8. Becton Dickinson Subcutaneous Injection Product and Solutions
Table 9. Becton Dickinson Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 11. Daiichi Sankyo Major Business
Table 12. Daiichi Sankyo Subcutaneous Injection Product and Solutions
Table 13. Daiichi Sankyo Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Subcutaneous Injection Product and Solutions
Table 17. Sanofi Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Subcutaneous Injection Product and Solutions
Table 21. Roche Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GSK Corporate Information, Head Office, and Major Competitors
Table 23. GSK Major Business
Table 24. GSK Subcutaneous Injection Product and Solutions
Table 25. GSK Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Subcutaneous Injection Product and Solutions
Table 29. Eli Lilly Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Asahi Kasei Pharma Corporate Information, Head Office, and Major Competitors
Table 31. Asahi Kasei Pharma Major Business
Table 32. Asahi Kasei Pharma Subcutaneous Injection Product and Solutions
Table 33. Asahi Kasei Pharma Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Takeda Pharmaceutical Major Business
Table 36. Takeda Pharmaceutical Subcutaneous Injection Product and Solutions
Table 37. Takeda Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Antares Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Antares Pharma, Inc. Major Business
Table 40. Antares Pharma, Inc. Subcutaneous Injection Product and Solutions
Table 41. Antares Pharma, Inc. Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Eisai Co.?Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Eisai Co.?Ltd Major Business
Table 44. Eisai Co.?Ltd Subcutaneous Injection Product and Solutions
Table 45. Eisai Co.?Ltd Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Chugai Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Chugai Pharmaceutical Major Business
Table 48. Chugai Pharmaceutical Subcutaneous Injection Product and Solutions
Table 49. Chugai Pharmaceutical Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Endo International Corporate Information, Head Office, and Major Competitors
Table 51. Endo International Major Business
Table 52. Endo International Subcutaneous Injection Product and Solutions
Table 53. Endo International Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. PenJet Corporation Corporate Information, Head Office, and Major Competitors
Table 55. PenJet Corporation Major Business
Table 56. PenJet Corporation Subcutaneous Injection Product and Solutions
Table 57. PenJet Corporation Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Aspen Medical Group Corporate Information, Head Office, and Major Competitors
Table 59. Aspen Medical Group Major Business
Table 60. Aspen Medical Group Subcutaneous Injection Product and Solutions
Table 61. Aspen Medical Group Subcutaneous Injection Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Subcutaneous Injection Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Subcutaneous Injection Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Subcutaneous Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Subcutaneous Injection Players Head Office, Products and Services Provided
Table 66. Subcutaneous Injection Mergers & Acquisitions in the Past Five Years
Table 67. Subcutaneous Injection New Entrants and Expansion Plans
Table 68. Global Subcutaneous Injection Revenue (USD Million) by Type (2017-2022)
Table 69. Global Subcutaneous Injection Revenue Share by Type (2017-2022)
Table 70. Global Subcutaneous Injection Revenue Forecast by Type (2023-2028)
Table 71. Global Subcutaneous Injection Revenue by Application (2017-2022)
Table 72. Global Subcutaneous Injection Revenue Forecast by Application (2023-2028)
Table 73. North America Subcutaneous Injection Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Subcutaneous Injection Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Subcutaneous Injection Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Subcutaneous Injection Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Subcutaneous Injection Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Subcutaneous Injection Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Subcutaneous Injection Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Subcutaneous Injection Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Subcutaneous Injection Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Subcutaneous Injection Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Subcutaneous Injection Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Subcutaneous Injection Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Subcutaneous Injection Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Subcutaneous Injection Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Subcutaneous Injection Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Subcutaneous Injection Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Subcutaneous Injection Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Subcutaneous Injection Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Subcutaneous Injection Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Subcutaneous Injection Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Subcutaneous Injection Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Subcutaneous Injection Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Subcutaneous Injection Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Subcutaneous Injection Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Subcutaneous Injection Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Subcutaneous Injection Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Subcutaneous Injection Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Subcutaneous Injection Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Subcutaneous Injection Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Subcutaneous Injection Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Subcutaneous Injection Picture
Figure 2. Global Subcutaneous Injection Revenue Market Share by Type in 2021
Figure 3. Subcutaneous Injection Equipment
Figure 4. Subcutaneous Injection Drug
Figure 5. Others
Figure 6. Subcutaneous Injection Revenue Market Share by Application in 2021
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Subcutaneous Injection Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Subcutaneous Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Subcutaneous Injection Revenue Market Share by Region (2017-2028)
Figure 14. Global Subcutaneous Injection Revenue Market Share by Region in 2021
Figure 15. North America Subcutaneous Injection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Subcutaneous Injection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Subcutaneous Injection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Subcutaneous Injection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Subcutaneous Injection Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Subcutaneous Injection Market Drivers
Figure 21. Subcutaneous Injection Market Restraints
Figure 22. Subcutaneous Injection Market Trends
Figure 23. Becton Dickinson Recent Developments and Future Plans
Figure 24. Daiichi Sankyo Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. GSK Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. Asahi Kasei Pharma Recent Developments and Future Plans
Figure 30. Takeda Pharmaceutical Recent Developments and Future Plans
Figure 31. Antares Pharma, Inc. Recent Developments and Future Plans
Figure 32. Eisai Co.?Ltd Recent Developments and Future Plans
Figure 33. Chugai Pharmaceutical Recent Developments and Future Plans
Figure 34. Endo International Recent Developments and Future Plans
Figure 35. PenJet Corporation Recent Developments and Future Plans
Figure 36. Aspen Medical Group Recent Developments and Future Plans
Figure 37. Global Subcutaneous Injection Revenue Share by Players in 2021
Figure 38. Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Subcutaneous Injection Revenue Market Share in 2021
Figure 40. Global Top 10 Players Subcutaneous Injection Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Subcutaneous Injection Revenue Share by Type in 2021
Figure 43. Global Subcutaneous Injection Market Share Forecast by Type (2023-2028)
Figure 44. Global Subcutaneous Injection Revenue Share by Application in 2021
Figure 45. Global Subcutaneous Injection Market Share Forecast by Application (2023-2028)
Figure 46. North America Subcutaneous Injection Sales Market Share by Type (2017-2028)
Figure 47. North America Subcutaneous Injection Sales Market Share by Application (2017-2028)
Figure 48. North America Subcutaneous Injection Revenue Market Share by Country (2017-2028)
Figure 49. United States Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Subcutaneous Injection Sales Market Share by Type (2017-2028)
Figure 53. Europe Subcutaneous Injection Sales Market Share by Application (2017-2028)
Figure 54. Europe Subcutaneous Injection Revenue Market Share by Country (2017-2028)
Figure 55. Germany Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Subcutaneous Injection Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Subcutaneous Injection Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Subcutaneous Injection Revenue Market Share by Region (2017-2028)
Figure 63. China Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Subcutaneous Injection Sales Market Share by Type (2017-2028)
Figure 70. South America Subcutaneous Injection Sales Market Share by Application (2017-2028)
Figure 71. South America Subcutaneous Injection Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Subcutaneous Injection Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Subcutaneous Injection Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Subcutaneous Injection Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Subcutaneous Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
